IL54590A - Derivatives of 7-(5-indanyl)or 7-(5,6,7,8-tetrahydro-2-naphthyl)-3-methyl-octa-2,4,6-trienoic acid,their manufacture and pharmaceutical compositions containing them - Google Patents

Derivatives of 7-(5-indanyl)or 7-(5,6,7,8-tetrahydro-2-naphthyl)-3-methyl-octa-2,4,6-trienoic acid,their manufacture and pharmaceutical compositions containing them

Info

Publication number
IL54590A
IL54590A IL54590A IL5459078A IL54590A IL 54590 A IL54590 A IL 54590A IL 54590 A IL54590 A IL 54590A IL 5459078 A IL5459078 A IL 5459078A IL 54590 A IL54590 A IL 54590A
Authority
IL
Israel
Prior art keywords
octa
indanyl
tetrahydro
naphthyl
derivatives
Prior art date
Application number
IL54590A
Other languages
English (en)
Other versions
IL54590A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Priority to IL61697A priority Critical patent/IL61697A/xx
Publication of IL54590A0 publication Critical patent/IL54590A0/xx
Publication of IL54590A publication Critical patent/IL54590A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/38—Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/50—Halogenated unsaturated alcohols containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/792—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL54590A 1977-05-04 1978-04-27 Derivatives of 7-(5-indanyl)or 7-(5,6,7,8-tetrahydro-2-naphthyl)-3-methyl-octa-2,4,6-trienoic acid,their manufacture and pharmaceutical compositions containing them IL54590A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL61697A IL61697A (en) 1977-05-04 1978-04-27 1-(substituted-5-indanyl(or 2-tetrahydronaphthyl))ethyl triphenyl phosphonium salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77254A LU77254A1 (cs) 1977-05-04 1977-05-04

Publications (2)

Publication Number Publication Date
IL54590A0 IL54590A0 (en) 1978-07-31
IL54590A true IL54590A (en) 1982-02-28

Family

ID=19728555

Family Applications (2)

Application Number Title Priority Date Filing Date
IL54590A IL54590A (en) 1977-05-04 1978-04-27 Derivatives of 7-(5-indanyl)or 7-(5,6,7,8-tetrahydro-2-naphthyl)-3-methyl-octa-2,4,6-trienoic acid,their manufacture and pharmaceutical compositions containing them
IL61697A IL61697A0 (en) 1977-05-04 1980-12-12 Phosphonium salts

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL61697A IL61697A0 (en) 1977-05-04 1980-12-12 Phosphonium salts

Country Status (32)

Country Link
US (1) US4193931A (cs)
JP (1) JPS53137940A (cs)
AR (1) AR220704A1 (cs)
AT (1) AT356647B (cs)
AU (1) AU522598B2 (cs)
BE (1) BE866651A (cs)
BR (1) BR7802807A (cs)
CA (1) CA1114830A (cs)
CH (2) CH641755A5 (cs)
CS (1) CS214853B2 (cs)
CU (1) CU21105A (cs)
DE (1) DE2819213A1 (cs)
DK (1) DK155730C (cs)
ES (2) ES469394A1 (cs)
FI (1) FI66587C (cs)
FR (1) FR2390428A1 (cs)
GB (2) GB1600915A (cs)
GR (1) GR74426B (cs)
HU (1) HU183088B (cs)
IE (1) IE46946B1 (cs)
IL (2) IL54590A (cs)
IT (1) IT1096278B (cs)
LU (1) LU77254A1 (cs)
MC (1) MC1193A1 (cs)
MY (1) MY8500250A (cs)
NL (1) NL7804773A (cs)
NO (1) NO148290C (cs)
NZ (1) NZ187114A (cs)
PH (1) PH14216A (cs)
PT (1) PT67988B (cs)
SE (1) SE436644B (cs)
ZA (1) ZA782415B (cs)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216312A (en) * 1978-08-24 1980-08-05 Hoffmann-La Roche Inc. Furyl substituted polyenes
FI67386C (fi) * 1979-06-21 1985-03-11 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sockerderivat
CH651007A5 (de) * 1982-06-24 1985-08-30 Hoffmann La Roche Polyenverbindungen.
DK158947C (da) * 1982-07-06 1991-01-21 Hoffmann La Roche Tetrahydronaphthalin-,benzofuran- og benzothiophenderivater, fremstilling og anvendelse deraf samt rodenticid indeholdende saadanne derivater
US4529600A (en) * 1982-09-09 1985-07-16 Sri International Pentadeuterioretinoids
US4439614A (en) * 1982-09-22 1984-03-27 Sri International 5,6-Methano-5,6-dihydroretinoids
US4464389A (en) * 1982-10-20 1984-08-07 Sri International Esters of retinoic acid and pentaerythritol and monobenzal acetals thereof
US4539154A (en) * 1983-06-15 1985-09-03 Hoffmann-La Roche Inc. Polyene compounds
CH661516A5 (de) * 1983-12-08 1987-07-31 Hoffmann La Roche Phenylnonatetraenoylzuckerderivate.
US4783549A (en) * 1984-09-05 1988-11-08 L'oreal Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them
FR2580277B1 (fr) * 1985-04-15 1988-06-10 Oreal Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant
ZW7487A1 (en) * 1986-05-23 1987-12-16 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
AT388728B (de) * 1987-03-17 1989-08-25 Hoffmann La Roche Neue tetrahydronaphthalin- und indanderivate
US5250562A (en) * 1988-02-24 1993-10-05 Hoffmann-La Roche Inc. Stilbene derivatives
US5248696A (en) * 1991-04-18 1993-09-28 World Research Institute For Science And Technology, Inc. Composition and method for treating tumors
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
CA2129773C (en) * 1993-09-02 2007-05-01 Michael Klaus Aromatic carboxylic acid derivatives
FR2719041B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DE69516903T2 (de) * 1994-12-30 2000-10-26 Ligand Pharmaceuticals, Inc. Retinoid trienverbindungen und verfahren
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
DK0873295T3 (da) * 1995-10-06 2003-07-14 Ligand Pharm Inc Dimer-selektive RXR-modulatorer og fremgangsmåder til deres anvendelse
US6112489A (en) * 1995-12-12 2000-09-05 Monotech International, Inc. Monocoque concrete structures
WO1998007716A2 (en) * 1996-08-23 1998-02-26 The Board Of Regents For Oklahoma State University Heteroarotinoids-anticancer agents with receptor specificity and tgase activity
FR2752837B1 (fr) * 1996-09-02 1999-11-12 Cird Galderma Nouveaux composes modulateurs des recepteurs hormonaux, les compositions les comprenant et leur utilisation en therapie
US7098025B1 (en) * 1997-07-25 2006-08-29 Ligand Pharmaceuticals Incorporated Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
US6534545B1 (en) 1997-09-25 2003-03-18 Galderma Research & Development Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and cosmetics
FR2768731B1 (fr) * 1997-09-25 1999-12-10 Cird Galderma Derives insatures en position -4 du 6-tert-butyl-1,1- dimethylindane et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
CA2334545A1 (en) * 1998-06-12 1999-12-16 Ligand Pharmaceuticals Incorporated Treatment of anti-estrogen resistant breast cancer using rxr modulators
BR0013597A (pt) 1999-08-27 2002-07-16 Ligand Pharm Inc Compostos e métodos moduladores de receptor de androgênio
AU6941200A (en) 1999-08-27 2001-03-26 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido(3,2-g)quinoline compounds as androgen receptor modulators
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
PE20010647A1 (es) 1999-09-14 2001-06-23 Lilly Co Eli Moduladores de receptores de retinoide x (rxr) con perfil farmacologico mejorado
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7314953B2 (en) * 2001-03-27 2008-01-01 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US6586460B1 (en) 2001-04-02 2003-07-01 The Board Of Regents For Oklahoma State University Heteroarotinoids containing urea or thiourea linker
CA2486303C (en) * 2002-05-22 2013-04-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
US9050310B2 (en) * 2004-06-25 2015-06-09 Minas Theodore Coroneo Treatment of ocular lesions
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20060204474A1 (en) * 2005-02-25 2006-09-14 Coroneo Minas T Treatment of epithelial layer lesions
WO2012076842A1 (en) * 2010-12-09 2012-06-14 University Of Durham Synthetic retinoids for control of cell differentiation
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas
JP7416687B2 (ja) * 2017-09-28 2024-01-17 ジョンソン アンド ジョンソン コンシューマー インコーポレイテッド 化粧品組成物及び皮膚の処置方法
CA3107707A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452085A (en) * 1966-02-11 1969-06-24 Carbo Erba Spa Alpha-(5-indanyl)-butyric acid
US3781314A (en) * 1971-07-14 1973-12-25 Hoffmann La Roche Polyene compounds
BE793108A (fr) * 1971-12-22 1973-06-21 Hoffmann La Roche Derives polyeniques
FR2235679B1 (cs) * 1973-07-02 1978-07-21 Takeda Chemical Industries Ltd
CH582668A5 (cs) * 1973-08-10 1976-12-15 Hoffmann La Roche
CH585709A5 (cs) * 1973-08-24 1977-03-15 Hoffmann La Roche
CH592598A5 (cs) * 1973-10-30 1977-10-31 Hexachimie
AR206619A1 (es) * 1974-02-07 1976-08-06 Hexachimie Procedimiento para peparar acidos 5-indanilaceticos
FR2276035A1 (fr) * 1974-06-28 1976-01-23 Lipha Nouveaux derives de l'indane
JPS51125235A (en) * 1974-09-26 1976-11-01 Hoffmann La Roche Preparation of polyene compounds
US4054589A (en) * 1974-09-26 1977-10-18 Hoffmann-La Roche Inc. Novel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene esters

Also Published As

Publication number Publication date
GB1600915A (en) 1981-10-21
ES475240A1 (es) 1979-05-16
CH641755A5 (de) 1984-03-15
BE866651A (fr) 1978-11-03
FI781227A (fi) 1978-11-05
DK195378A (da) 1978-11-05
ES469394A1 (es) 1979-02-01
GR74426B (cs) 1984-06-28
FI66587C (fi) 1984-11-12
IT7823003A0 (it) 1978-05-04
IE780864L (en) 1978-11-04
HU183088B (en) 1984-04-28
ATA320478A (de) 1979-10-15
IE46946B1 (en) 1983-11-16
NO148290B (no) 1983-06-06
AR220704A1 (es) 1980-11-28
BR7802807A (pt) 1979-01-02
AU3576278A (en) 1979-11-08
AU522598B2 (en) 1982-06-17
CA1114830A (en) 1981-12-22
NO781586L (no) 1978-11-07
SE436644B (sv) 1985-01-14
PT67988B (en) 1980-05-05
IT1096278B (it) 1985-08-26
DE2819213A1 (de) 1978-11-16
CH642380A5 (de) 1984-04-13
DK155730B (da) 1989-05-08
GB1600914A (en) 1981-10-21
DE2819213C2 (cs) 1987-09-24
FR2390428B1 (cs) 1983-03-04
IL54590A0 (en) 1978-07-31
NZ187114A (en) 1980-11-14
CS214853B2 (en) 1982-06-25
CU21105A (es) 1981-12-04
FR2390428A1 (fr) 1978-12-08
SE7805136L (sv) 1978-11-05
NL7804773A (nl) 1978-11-07
JPS53137940A (en) 1978-12-01
IL61697A0 (en) 1981-01-30
DK155730C (da) 1989-10-02
US4193931A (en) 1980-03-18
MY8500250A (en) 1985-12-31
NO148290C (no) 1983-09-14
AT356647B (de) 1980-05-12
FI66587B (fi) 1984-07-31
PT67988A (en) 1978-06-01
ZA782415B (en) 1979-04-25
PH14216A (en) 1981-04-02
JPS6332777B2 (cs) 1988-07-01
LU77254A1 (cs) 1979-01-18
MC1193A1 (fr) 1979-02-23

Similar Documents

Publication Publication Date Title
IL54590A (en) Derivatives of 7-(5-indanyl)or 7-(5,6,7,8-tetrahydro-2-naphthyl)-3-methyl-octa-2,4,6-trienoic acid,their manufacture and pharmaceutical compositions containing them
IL51519A0 (en) Novel androstadiene-17-carboxylic acid esters their manufacture and pharmaceutical compositions containing them
IL54867A (en) Penicillanic acid 1,1-dioxide and esters and salts,their preparation and pharmaceutical compositions containing them
IL52280A0 (en) New derivatives of penicillanic acid their preparation and pharmaceutical compositions containing them
GR63213B (en) 4-trifluormethylbenzoic acid derivatives and process of making the same and pharmaceutical compositions containing thereof
IL52466A (en) 7(2-acyl-2-hydroxyiminoacetamido)-3-tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL52493A0 (en) 5-aroyl-pyrrolopyrrole-1-carboxylic acid derivatives their production and pharmaceutical compositions containing them
JPS52105168A (en) Production of 1*22 benzisothiazolinee33ones and use of same as pharmaceutical agent
JPS525768A (en) Novel propargyll22phenylaminoo imidazolinee*2* * acid adduct thereof * pharmaceutical agent containing same and production thereof
IL52717A0 (en) Novel derivatives of 2-phenylamino-imidazoline-(2), their preparation and pharmaceutical compositions containing them
IL54859A (en) Derivatives of amidinopenicillanic acid,their production and pharmaceutical compositions containing them
IL53926A (en) 5-substituted-2-oxo-2h(1,2,4)-oxadiazolo (2,3-a)-pyrimidine-7-cabamic acid esters,their manufacture and pharmaceutical compositions containing them
IL51267A0 (en) Novel clavulanic acid derivatives their preparation and pharmaceutical compositions containing them
NZ184408A (en) 16-s-acyl derivatives of 16-deacetoxy-fusidic acid and pharmaceutical compositions
IL54949A (en) Pharmaceutical compositions containing 4-hydroxy-2-oxoquinoline-3-carboxylic acid derivatives and novel compounds of this type
IL52638A0 (en) Novel olivanic acid derivatives their preparation and pharmaceutical compositions containing them
ZA784501B (en) Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof
NZ186059A (en) 3-sulphamoyl-5-pyrrolylal-kylbenzoic acid derivatives and pharmaceutical compositions
DE2967551D1 (en) 5(6)-(2-amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them
JPS52136156A (en) Production of novel 177 spirosultine derivatives and corresponding gammaa hydroxylic acid and pharmaceutical composition
IL54953A (en) Lactams of 4a-amino-hexahydrobenzopyrano(3,2-c)pyridine-10-acetic acid,their preparation and pharmaceutical compositions containing them
JPS5473769A (en) *22oxoopyrrolidinee1** and *22oxoopiperidinee 1**carboxylic acid derivatives*their manufacture and medical composition containing them
NZ189151A (en) Peptide derivatives of phosphonic acid and pharmaceutical compositions
IL55688A (en) 1,4-dihydropyridazine-5-carboxylic acid derivatives,their production and pharmaceutical compositions containing them
IL53567A0 (en) Novel derivatives of dithiosalicyclic acid amides their preparation and pharmaceutical compositions containing them